SCHEMBL20037557

SCHEMBL20037557

N#CCN1CCN(Cc2ccc(N)nc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.42
▸ MTOR P42345 3/20 0.40
▸ ATM Q13315 2/20 0.40
▸ FKBP1A P62942 1/20 0.40
▸ FKBP1B P68106 1/20 0.40
▸ PRKDC P78527 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GABRP O00591 1/20 0.38
▸ GABRD O14764 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB1 P18505 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ GABRA2 P47869 1/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ GABRA4 P48169 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19231861 0.85 ALDH1A1 (0.46) MTORPOLBMEN1KMT2ALMNA
SCHEMBL20038438 0.82 POLB (0.45) LTA4HATMPOLBMEN1KMT2A
SCHEMBL20038437 0.82 LTA4H (0.42) LTA4HATMPOLBMEN1KMT2A
SCHEMBL1035345 0.80 ALDH1A1 (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1126048 0.80 ALDH1A1 (0.54) ATMPOLBMEN1KMT2AGABRP
SCHEMBL19171016 0.80 MEN1 (0.41) ATMMEN1KMT2AGABRPGABRD
SCHEMBL609436 0.80 LMNA (0.62) ATMMEN1KMT2ALMNAHRH3
SCHEMBL1126310 0.80 SIGMAR1 (0.60) POLBKMT2ALMNAALDH1A1
SCHEMBL22650374 0.79 ACHE (0.45) LTA4HMEN1KMT2AGABRPGABRD
SCHEMBL4267512 0.79 ALDH1A1 (0.59) POLBCHRNB2CHRNA4HRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback